Case study

Canada's Infectious Disease Vaccination Landscape: Expert Insights

In a bid to evaluate infectious disease vaccination programs in Canada, BTHT organized expert consultations that shed light on critical aspects such as healthcare budget priorities and vaccine strategies. These discussions provided the consulting firm with a comprehensive understanding of the vaccination landscape, enabling them to make well-informed strategic decisions and recommendations.

Canada's Infectious Disease Vaccination Landscape: Expert Insights
  • North America
  • Canada
  • Pharma

CHALLENGE

A leading strategy consultancy firm sought to gain an in-depth understanding of infectious diseases vaccination programs in Canada. The firm aimed to evaluate the current priorities, budgetary allocations, and recommendations related to infectious disease vaccination at both provincial and national levels.

To navigate the complexities of Canada’s vaccination landscape, the client required insights from high-level professionals with expertise in public health, vaccination policies, and pharmaceutical distribution.

BTHT APPROACH

The BTHT team focused on finding experts who can answer the critical aspects of the client's project such as healthcare budget priorities, vaccine recommendations, and allocation strategies. Our approach involved engaging with key opinion leaders (KOLs), decision-makers, and experts from pharmaceutical companies. The expert pipeline our team prepared for our client included:

  • Public Health Officials with extensive experience in provincial infectious disease vaccination programs
  • Federal Health Agency Representatives with insights into national vaccination policies
  • Public Health Experts specializing in infectious diseases and vaccination strategies
  • Former Senior Health Executives with expertise in vaccine implementation and policy development
  • Academic Researchers from prominent institutions involved in infectious disease vaccine research and recommendations
  • Industry Specialists from major pharmaceutical companies involved in infectious disease vaccine production and distribution.

1 hour consultations were organized by BTHT team, to provide a smooth process for our experts and client from technical and legal perspective.

OUTCOME

Through one-hour discussions with our experts, the client gained critical insights into Canada’s influenza vaccination programs. The consultations provided a deep understanding of vaccination priorities, budgetary allocations etc. This enabled the firm to assess strategic opportunities, equipping them with the knowledge needed to effectively navigate and influence the vaccination landscape in Canada.

Get in touch

Let's talk about your project

Reach our CEO Alexis Capelle directly or send us a message — we typically reply within one business day.